Translating cGMP analogues into a treatment for retinitis pigmentosa
Description of the granted funding
Inherited retinal degenerations, such as retinitis pigmentosa, cause loss of vision already at young age, because there is no cure to these diseases. In this project, new medication is being developed for the treatment of retinitis pigmentosa. The project aims to generate pre-clinical data that supports translation of the new medications to clinical studies. The role of University of Eastern Finland in this European project is related to formulation of the new compounds in nanostructures to reach targeted and prolonged drug activity.
Show moreStarting year
2021
End year
2024
Granted funding
Funder
Research Council of Finland
Funding instrument
Kansainvälinen yhteisrahoitteinen ohjelma
Other information
Funding decision number
344718
Fields of science
Biomedicine
Research fields
Biolääketieteet
Identified topics
eyes, eye diseases